1. |
Wingerchuk DM. Neuromyelitis optica: new findings on pathogenesis[J]. Int Rev Neurobiol, 2007, 79: 665-688. DOI: 10.1016/S0074-7742(07)79029-3.
|
2. |
Lan YL, Fang DY, Zhao J, et al. A research update on the potential roles of aquaporin 4 in neuroinflammation[J]. Acta Neurol Belg, 2016, 116(2): 127-134. DOI: 10.1007/s13760-015-0520-2.
|
3. |
Shams PN, Plant GT. Optic neuritis: a review[J]. Int MS J, 2009, 16(3): 82-89.
|
4. |
Lai C, Tian G, Liu W, et al. Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China[J]. J Neurol Sci, 2011, 305(1-2): 38-40. DOI: 10.1016/j.jns.2011.03.021.
|
5. |
Reeves HM, Winters JL. The mechanisms of action of plasma exchange[J]. Br J Haematol, 2014, 164(3): 342-351. DOI: 10.1111/bjh.12629.
|
6. |
Zhou H, Xu Q, Zhao S, et al. Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients[J]. Br J Ophthalmol, 2017, 101(12): 1720-1724. DOI: 10.1136/bjophthalmol-2017-310157.
|
7. |
Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue[J]. J Clin Apher, 2016, 31(3): 149-162. DOI: 10.1002/jca.21470.
|
8. |
Petzold A, Plant GT. Diagnosis and classification of autoimmune optic neuropathy[J]. Autoimmun Rev, 2014, 13(4-5): 539-545. DOI: 10.1016/j.autrev.2014.01.009.
|
9. |
Lehmann HC, Hartung HP, Hetzel GR, et al. Plasma exchange in neuroimmunological disorders: part 1: rationale and treatment of inflammatory central nervous system disorders[J]. Arch Neurol, 2006, 63(7): 930-935. DOI: 10.1001/archneur.63.7.930.
|
10. |
Kim SH, Kim W, Huh SY, et al. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels[J]. J Clin Neurol, 2013, 9(1): 36-42. DOI: 10.3988/jcn.2013.9.1.36.
|
11. |
Okafor C, Ward DM, Mokrzycki MH, et al. Introduction and overview of therapeutic apheresis[J]. J Clin Apher, 2010, 25(5): 240-249. DOI: 10.1002/jca.20247.
|